Emergency departments that see fewer pediatric patients are more likely to give delayed diagnoses for serious medical conditions compared to those who see pediatric patients more often, according to a Northwestern Medicine study published in JAMA Pediatrics.
Browsing: Pediatrics
The Pfizer BioNTech BNT162b2 vaccine was highly effective in preventing severe COVID-19 infections in children and adolescents during the Delta and Omicron variants, according to a large, national study recently published in the Annals of Internal Medicine.
The drug tovorafenib may halt the growth of or shrink some childhood brain tumors, according to a clinical trial published in Nature Medicine.
Babies of parents who speak a language other than English may be more likely to be unnecessarily hospitalized when visiting the emergency department for high fevers, according to a recent study published in JAMA Pediatrics.
Modulating the activity of a kinase in motor neurons may help mitigate mitochondrial defects and other symptoms of spinal muscular atrophy, offering a new therapeutic avenue for the devastating disease, according to a Northwestern Medicine study published in the Proceedings of the National Academy of Sciences (PNAS).
Northwestern scientists are introducing new soft, miniaturized wearable devices that continuously track subtle sounds simultaneously and wirelessly at multiple locations across nearly any region of the body.
A new Northwestern Medicine study has discovered a novel therapeutic target and therapeutic agents for older patients with acute respiratory distress syndrome, according to recent findings published in Science Translational Medicine.
A newly developed “peanut patch” is a safe and effective way to desensitize toddlers allergic to peanuts, according to findings published in The New England Journal of Medicine.
Fathers can make a significant difference in whether an infant is breastfed and placed to sleep safely, according to a recent survey of new fathers.
Using zebrafish models, investigators have discovered that MAP4K4 genetic variants cause neurodevelopmental delays and other physical abnormalities, demonstrating a potential therapeutic target for treating the disorder in humans, according to findings published in Science Advances.